LBF20309EO01: Difference between revisions
No edit summary |
No edit summary |
(No difference)
| |
Revision as of 06:00, 15 April 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA8113 |
| LipidMaps | - |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20309EO01 |
| (+-) 14 (15) -epoxy-5Z,8Z,11Z-eicosatrienoic acid | |
|---|---|
| |
| Structural Information | |
| (+-) 14 (15) -epoxy-5Z,8Z,11Z-eicosatrienoic acid | |
| |
| (±)14(15)-EpETrE | |
| Formula | C20H32O3 |
| Exact Mass | 320.23514489 |
| Average Mass | 320.46628 |
| SMILES | C(CCC(O1)C1CC=CCC=CCC=CCCCC(O)=O)CC |
| Physicochemical Information | |
| (±)14(15)-EpETrE is biosynthesized in rat and rabbit liver microsomes by cytochrome P450 Oliw_EH et al. Chacos_N et al.. | |
| Dramatic increases in urinary (±)14,15-DiHETrE, a (±)14(15)-EpETrE metabolite, have been documented by GC/MS in pregnancy induced hypertension Catella_F et al.. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
